Simtuzumab
id:
simtuzumab-258-445580
title:
Simtuzumab
text:
Simtuzumab is a humanized monoclonal antibody designed for the treatment of fibrosis. It binds to LOXL2 and acts as an immunomodulator. In January 2016, Gilead Sciences terminated its Phase 2 clinical study in patients with idiopathic pulmonary fibrosis (IPF) due to lack of efficacy.
brand slug:
wiki
category slug:
encyclopedia
description:
Monoclonal antibody
original url:
https://en.wikipedia.org/wiki/Simtuzumab
date created:
date modified:
2023-05-30T01:34:36Z
main entity:
{"identifier":"Q7521275","url":"https://www.wikidata.org/entity/Q7521275"}
image:
fields total:
13
integrity:
14